| Issue Date | Title | Author(s) |
| 1-Sep-2021 | A systematic review of the costs relating to non-pharmaceutical interventions against infectious disease outbreaks | Skarp, J; Downey, LE; Ohrnberger, JWE; Cilloni, L; Hogan, AB, et al |
| 17-Nov-2021 | Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage | Unwin, H; Mwandigha, L; Winskill, P; Ghani, A; Hogan, A, et al |
| 13-Oct-2020 | Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage | Unwin, HJT; Mwandigha, L; Winskill, P; Ghani, AC; Hogan, AB, et al |
| 10-Jan-2022 | Developing a prediction model to estimate the true burden of respiratory syncytial virus (RSV) in hospitalised children in Western Australia | Gebremedhin, AT; Hogan, AB; Blyth, CC; Glass, K; Moore, HC, et al |
| 30-Nov-2020 | Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: a modelling study | Hogan, A; Winskill, P; Ghani, A; |
| Sep-2022 | Global impact of the first year of COVID-19 vaccination: a mathematical modelling study | Watson, O; Barnsley, G; Toor, J; Hogan, A; Winskill, P, et al |
| 24-Jun-2021 | Health inequities and clustering of fever, acute respiratory infection, diarrhoea and wasting in children under five in low- and middle-income countries: a Demographic and Health Surveys analysis | Winskill, P; Hogan, AB; Thwing, J; Mwandigha, L; Walker, PGT, et al |
| 12-Nov-2020 | Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting | Campbell, P; Geard, N; Hogan, A; |
| 13-Jul-2021 | Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand | Prasad, N; Read, JM; Jewell, C; Waite, B; Trenholme, AA, et al |
| 3-Nov-2020 | Modelling the roles of antibody titre and avidity in protection from Plasmodium falciparum malaria infection following RTS,S/AS01 vaccination | Thompson, H; Hogan, A; Walker, P; White, M; Cunnington, A, et al |
| 1-Sep-2020 | Potential impact of the COVID-19 pandemic on HIV, TB and malaria in low- and middle-income countries: a modelling study | Hogan, A; Jewell, B; Sherrard-Smith, E; Watson, O; Whittaker, C, et al |
| 1-Dec-2022 | Seasonal use case for the RTS,S/AS01 malaria vaccine: a mathematical modelling study | Thompson, HA; Hogan, AB; Walker, PGT; Winskill, P; Zongo, I, et al |
| 7-Aug-2020 | The potential public health consequences of COVID-19 on malaria in Africa. | Sherrard-Smith, E; Hogan, AB; Hamlet, A; Watson, OJ; Whittaker, C, et al |
| 20-Mar-2021 | Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: a mathematical modelling analysis | Hogan, AB; Winskill, P; Watson, OJ; Walker, PGT; Whittaker, C, et al |
| 21-May-2021 | Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: a mathematical modelling analysis | Hogan, AB; Winskill, P; Watson, OJ; Walker, PGT; Whittaker, C, et al |